Jacobo E Mintzer

Title
InstitutionMedical University of South Carolina
DepartmentHealth Studies
AddressP.O. Box MSC 861
5900 Core Rd. Suite 203, N Charleston, SC
Phone843-740-1592
Fax843-740-6113
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Alzheimers, Ethnicity and Disease, Memory Loss, Aging, Drug Studies, Dementia, Geriatrics, Brain, Minorities

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sano M, Cummings J, Auer S, Bergh S, Fischer CE, Gerritsen D, Grossberg G, Ismail Z, Lanct?t K, Lapid MI, Mintzer J, Palm R, Rosenberg PB, Splaine M, Zhong K, Zhu CW. Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition. Int Psychogeriatr. 2023 Mar 07; 1-13. PMID: 36880250.
      Citations:    Fields:    
    2. Cummings J, Sano M, Auer S, Bergh S, Fischer CE, Gerritsen D, Grossberg G, Ismail Z, Lanct?t K, Lapid MI, Mintzer J, Palm R, Rosenberg PB, Splaine M, Zhong K, Zhu CW. Reduction and prevention of agitation in persons with neurocognitive disorders: an international psychogeriatric association consensus algorithm. Int Psychogeriatr. 2023 Mar 06; 1-12. PMID: 36876335.
      Citations:    Fields:    
    3. Miller MC, Salgado G, Nasrallah N, Bronson J, Sabatino CP, Mintzer J. Dementia in the incarcerated population: a retrospective study using the South Carolina Alzheimer's disease registry, USA. Int J Prison Health. 2023 02 27; ahead-of-print(ahead-of-print). PMID: 36821370.
      Citations:    Fields:    Translation:Humans
    4. Huang X, Li Y, Fowler C, Doecke JD, Lim YY, Drysdale C, Zhang V, Park K, Trounson B, Pertile K, Rumble R, Pickering JW, Rissman RA, Sarsoza F, Abdel-Latif S, Lin Y, Dor? V, Villemagne V, Rowe CC, Fripp J, Martins R, Wiley JS, Maruff P, Mintzer JE, Masters CL, Gu BJ. Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease. Alzheimers Dement. 2022 Nov 09. PMID: 36349985.
      Citations:    Fields:    
    5. Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D, Mintzer J, Lanct?t KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D, ADMET 2 Research Group. Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. JAMA Neurol. 2021 11 01; 78(11):1324-1332. PMID: 34570180; PMCID: PMC8477302.
      Citations:    
    6. Spira AP, Zipunnikov V, Raman R, Choi J, Di J, Bai J, Carlsson CM, Mintzer JE, Marshall GA, Porsteinsson AP, Yaari R, Wanigatunga SK, Kim J, Wu MN, Aisen PS, Sperling RA, Rosenberg PB, Spira AP, Zipunnikov V, Raman R, Choi J, Di J, Bai J, Carlsson CM, Mintzer JE, Marshall GA, Porsteinsson AP, Yaari R, Wanigatunga SK, Kim J, Wu MN, Aisen PS, Sperling RA, Rosenberg PB. Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies. Sleep Adv. 2021; 2(1):zpab015. PMID: 34661109; PMCID: PMC8519157.
      Citations:    
    7. Miller DS, Robert P, Ereshefsky L, Adler L, Bateman D, Cummings J, DeKosky ST, Fischer CE, Husain M, Ismail Z, Jaeger J, Lerner AJ, Li A, Lyketsos CG, Manera V, Mintzer J, Moebius HJ, Mortby M, Meulien D, Pollentier S, Porsteinsson A, Rasmussen J, Rosenberg PB, Ruthirakuhan MT, Sano M, Zucchero Sarracini C, Lanctôt KL, Miller DS, Robert P, Ereshefsky L, Adler L, Bateman D, Cummings J, DeKosky ST, Fischer CE, Husain M, Ismail Z, Jaeger J, Lerner AJ, Li A, Lyketsos CG, Manera V, Mintzer J, Moebius HJ, Mortby M, Meulien D, Pollentier S, Porsteinsson A, Rasmussen J, Rosenberg PB, Ruthirakuhan MT, Sano M, Zucchero Sarracini C, Lanct?t KL. Diagnostic criteria for apathy in neurocognitive disorders. Alzheimers Dement. 2021 12; 17(12):1892-1904. PMID: 33949763; PMCID: PMC8835377.
      Citations:    
    8. Liss JL, Seleri Assunção S, Cummings J, Atri A, Geldmacher DS, Candela SF, Devanand DP, Fillit HM, Susman J, Mintzer J, Bittner T, Brunton SA, Kerwin DR, Jackson WC, Small GW, Grossberg GT, Clevenger CK, Cotter V, Stefanacci R, Wise-Brown A, Sabbagh MN, Liss JL, Seleri Assun??o S, Cummings J, Atri A, Geldmacher DS, Candela SF, Devanand DP, Fillit HM, Susman J, Mintzer J, Bittner T, Brunton SA, Kerwin DR, Jackson WC, Small GW, Grossberg GT, Clevenger CK, Cotter V, Stefanacci R, Wise-Brown A, Sabbagh MN. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis. J Intern Med. 2021 08; 290(2):310-334. PMID: 33458891; PMCID: PMC8359937.
      Citations:    
    9. Brawman-Mintzer O, Tang XC, Bizien M, Harvey PD, Horner MD, Arciniegas DB, Raskind M, Johnson-Greene L, Martineau RJ, Hamner M, Rodriguez-Suarez M, Jorge RE, McGarity S, Wortzel HS, Wei Y, Sindowski T, Mintzer J, Kindy AZ, Donovan K, Reda D, Brawman-Mintzer O, Tang XC, Bizien M, Harvey PD, Horner MD, Arciniegas DB, Raskind M, Johnson-Greene L, Martineau RJ, Hamner M, Rodriguez-Suarez M, Jorge RE, McGarity S, Wortzel HS, Wei Y, Sindowski T, Mintzer J, Kindy AZ, Donovan K, Reda D. Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial. J Neurotrauma. 2021 07 15; 38(14):1943-1952. PMID: 33514274.
      Citations:    
    10. Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE, Lanct?t KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments. Am J Geriatr Psychiatry. 2021 01; 29(1):81-89. PMID: 32565008; PMCID: PMC7704818.
      Citations:    
    11. van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB, van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanct?t KL, Rosenberg PB. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate. Am J Geriatr Psychiatry. 2021 01; 29(1):51-62. PMID: 32461027; PMCID: PMC7641967.
      Citations:    
    12. Mintzer J, Donovan KA, Kindy AZ, Lock SL, Chura LR, Barracca N, Mintzer J, Donovan KA, Kindy AZ, Lock SL, Chura LR, Barracca N. Lifestyle Choices and Brain Health. Front Med (Lausanne). 2019; 6:204. PMID: 31637242; PMCID: PMC6787147.
      Citations:    
    13. Ehrhardt S, Porsteinsson AP, Munro CA, Rosenberg PB, Pollock BG, Devanand DP, Mintzer J, Rajji TK, Ismail Z, Schneider LS, Baksh SN, Drye LT, Avramopoulos D, Shade DM, Lyketsos CG, Ehrhardt S, Porsteinsson AP, Munro CA, Rosenberg PB, Pollock BG, Devanand DP, Mintzer J, Rajji TK, Ismail Z, Schneider LS, Baksh SN, Drye LT, Avramopoulos D, Shade DM, Lyketsos CG, S-CitAD Research Group. Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial. Alzheimers Dement. 2019 11; 15(11):1427-1436. PMID: 31587995; PMCID: PMC6889953.
      Citations:    
    14. Miller M, Orwat D, Rahimi G, Mintzer J, Miller M, Orwat D, Rahimi G, Mintzer J. A retrospective, population-based cohort study of driving under the influence, Alzheimer's disease diagnosis, and survival. Int Psychogeriatr. 2019 04; 31(4):571-577. PMID: 30303050.
      Citations:    
    15. Tao Y, Peters ME, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Munro CA, Tao Y, Peters ME, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Munro CA. Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2018 11; 33(7):450-457. PMID: 29969907; PMCID: PMC6219457.
      Citations:    
    16. Scherer RW, Drye L, Mintzer J, Lanctôt K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH, Scherer RW, Drye L, Mintzer J, Lanct?t K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH, ADMET 2 Research Group. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials. 2018 Jan 18; 19(1):46. PMID: 29347996; PMCID: PMC5774109.
      Citations:    
    17. Mohammad D, Ellis C, Rau A, Rosenberg PB, Mintzer J, Ruthirakuhan M, Herrmann N, Lanctôt KL, Mohammad D, Ellis C, Rau A, Rosenberg PB, Mintzer J, Ruthirakuhan M, Herrmann N, Lanct?t KL. Psychometric Properties of Apathy Scales in Dementia: A Systematic Review. J Alzheimers Dis. 2018; 66(3):1065-1082. PMID: 30400094.
      Citations:    
    18. Sano M, Soto M, Carrillo M, Cummings J, Hendrix S, Mintzer J, Porsteinsson A, Rosenberg P, Schneider L, Touchon J, Aisen P, Vellas B, Lyketsos C, Sano M, Soto M, Carrillo M, Cummings J, Hendrix S, Mintzer J, Porsteinsson A, Rosenberg P, Schneider L, Touchon J, Aisen P, Vellas B, Lyketsos C. Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force. J Prev Alzheimers Dis. 2018; 5(2):98-102. PMID: 29616702; PMCID: PMC6441964.
      Citations:    
    19. Patel AN, Lee S, Andrews HF, Pelton GH, Schultz SK, Sultzer DL, Mintzer J, de la Pena D, Gupta S, Colon S, Schimming C, Levin B, Devanand DP, Patel AN, Lee S, Andrews HF, Pelton GH, Schultz SK, Sultzer DL, Mintzer J, de la Pena D, Gupta S, Colon S, Schimming C, Levin B, Devanand DP. Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations. Am J Psychiatry. 2017 04 01; 174(4):362-369. PMID: 27855483; PMCID: PMC5378647.
      Citations:    
    20. Rosenberg PB, Lanctôt KL, Herrmann N, Mintzer JE, Porsteinsson AP, Sun X, Raman R, Rosenberg PB, Lanct?t KL, Herrmann N, Mintzer JE, Porsteinsson AP, Sun X, Raman R. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of?Alzheimer's Disease. J Alzheimers Dis. 2016 08 10; 54(1):373-81. PMID: 27567808.
      Citations:    
    21. Ho T, Pollock BG, Mulsant BH, Schantz O, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Drye LT, Munro CA, Shade DM, Lyketsos C, Bies R, Ho T, Pollock BG, Mulsant BH, Schantz O, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Drye LT, Munro CA, Shade DM, Lyketsos C, Bies R. R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. Br J Clin Pharmacol. 2016 09; 82(3):784-92. PMID: 27145364; PMCID: PMC6445501.
      Citations:    
    22. Yesavage JA, Taylor JL, Friedman L, Rosenberg PB, Lazzeroni LC, Leoutsakos JS, Kinoshita LM, Perlow MJ, Munro CA, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A, Yesavage JA, Taylor JL, Friedman L, Rosenberg PB, Lazzeroni LC, Leoutsakos JS, Kinoshita LM, Perlow MJ, Munro CA, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A, CitAD Research Group. Principal components analysis of agitation outcomes in Alzheimer's disease. J Psychiatr Res. 2016 08; 79:4-7. PMID: 27115509; PMCID: PMC4891245.
      Citations:    
    23. Leonpacher AK, Peters ME, Drye LT, Makino KM, Newell JA, Devanand DP, Frangakis C, Munro CA, Mintzer JE, Pollock BG, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Porsteinsson AP, Leonpacher AK, Peters ME, Drye LT, Makino KM, Newell JA, Devanand DP, Frangakis C, Munro CA, Mintzer JE, Pollock BG, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Porsteinsson AP, CitAD Research Group. Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study. Am J Psychiatry. 2016 May 01; 173(5):473-80. PMID: 27032628.
      Citations:    
    24. Schneider LS, Frangakis C, Drye LT, Devanand DP, Marano CM, Mintzer J, Mulsant BH, Munro CA, Newell JA, Pawluczyk S, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rein L, Rosenberg PB, Shade D, Weintraub D, Yesavage J, Lyketsos CG, Schneider LS, Frangakis C, Drye LT, Devanand DP, Marano CM, Mintzer J, Mulsant BH, Munro CA, Newell JA, Pawluczyk S, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rein L, Rosenberg PB, Shade D, Weintraub D, Yesavage J, Lyketsos CG, CitAD Research Group. Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial. Am J Psychiatry. 2016 May 01; 173(5):465-72. PMID: 26771737; PMCID: PMC6419726.
      Citations:    
    25. Newell J, Yesavage JA, Taylor JL, Kraemer HC, Munro CA, Friedman L, Rosenberg PB, Madore M, Chao SZ, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A, Newell J, Yesavage JA, Taylor JL, Kraemer HC, Munro CA, Friedman L, Rosenberg PB, Madore M, Chao SZ, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A, CitAD Research Group. Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease. J Psychiatr Res. 2016 Mar; 74:17-21. PMID: 26736036; PMCID: PMC4744510.
      Citations:    
    26. Akil A, Bies RR, Pollock BG, Avramopoulos D, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Shade DM, Lyketsos CG, Akil A, Bies RR, Pollock BG, Avramopoulos D, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Shade DM, Lyketsos CG. A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation. J Pharmacokinet Pharmacodyn. 2016 Feb; 43(1):99-109. PMID: 26611790; PMCID: PMC4720707.
      Citations:    
    27. Pravatà E, Tavernier J, Parker R, Vavro H, Mintzer JE, Spampinato MV, Pravat? E, Tavernier J, Parker R, Vavro H, Mintzer JE, Spampinato MV. The neural correlates of anomia in the conversion from mild cognitive impairment to Alzheimer's disease. Neuroradiology. 2016 Jan; 58(1):59-67. PMID: 26400852.
      Citations:    
    28. Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS, Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS, Alzheimer's Disease Cooperative Study. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015 Oct 20; 85(16):1383-91. PMID: 26362286; PMCID: PMC4626244.
      Citations:    
    29. Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PN, Siffert J, Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PN, Siffert J. Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial. JAMA. 2015 Sep 22-29; 314(12):1242-54. PMID: 26393847.
      Citations:    
    30. Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Weintraub D, Newell J, Yesavage J, Lyketsos CG, Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Weintraub D, Newell J, Yesavage J, Lyketsos CG, CitAD Research Group. Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial. Int Psychogeriatr. 2015 Dec; 27(12):2059-67. PMID: 26305876; PMCID: PMC4669064.
      Citations:    
    31. Peters ME, Vaidya V, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Avramopoulos D, Peters ME, Vaidya V, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Avramopoulos D, CitAD Research Group. Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences. J Geriatr Psychiatry Neurol. 2016 Mar; 29(2):59-64. PMID: 26303700; PMCID: PMC5166612.
      Citations:    
    32. Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Yesavage J, Lyketsos CG, Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Yesavage J, Lyketsos CG, CitAD Research Group. Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease. Am J Geriatr Psychiatry. 2015 Nov; 23(11):1127-33. PMID: 26238225; PMCID: PMC4653092.
      Citations:    
    33. Fernandes L, Mateos R, Engedal K, von Gunten A, Stek ML, Ramakrishnan A, Ihl R, Wang H, Mintzer J, Brodaty H, Fernandes L, Mateos R, Engedal K, von Gunten A, Stek ML, Ramakrishnan A, Ihl R, Wang H, Mintzer J, Brodaty H. The state of psychogeriatrics in Europe: challenges and opportunities in six European countries. Int Psychogeriatr. 2015 Aug; 27(8):1243-6. PMID: 25355137.
      Citations:    
    34. Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, Gauthier S, Howard R, Lanctôt K, Lyketsos CG, Peskind E, Porsteinsson AP, Reich E, Sampaio C, Steffens D, Wortmann M, Zhong K, Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, Gauthier S, Howard R, Lanct?t K, Lyketsos CG, Peskind E, Porsteinsson AP, Reich E, Sampaio C, Steffens D, Wortmann M, Zhong K, International Psychogeriatric Association. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. Int Psychogeriatr. 2015 Jan; 27(1):7-17. PMID: 25311499; PMCID: PMC4301197.
      Citations:    
    35. Ruiz A, Hernández I, Ronsende-Roca M, González-Pérez A, Rodriguez-Noriega E, Ramírez-Lorca R, Mauleón A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayán J, Becker JT, Real LM, Tárraga L, Ballard C, Terrin M, Sherman S, Payami H, López OL, Mintzer JE, Boada M, Ruiz A, Hern?ndez I, Ronsende-Roca M, Gonz?lez-P?rez A, Rodriguez-Noriega E, Ram?rez-Lorca R, Maule?n A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gay?n J, Becker JT, Real LM, T?rraga L, Ballard C, Terrin M, Sherman S, Payami H, L?pez OL, Mintzer JE, Boada M. Erratum to "Exploratory analysis of seven Alzheimer's disease genes: disease progression" [Neurobiol. Aging 34 (2013) 1310.e1-1310.e7]. Neurobiol Aging. 2014 Nov; 35(11):2661. PMID: 28911722.
      Citations:    
    36. Orr RK, Hoehn JL, Col NF, Balasubramanian S, Mintzer JE, Wahlquist AE. Induction of salivary nerve growth factor by Yogic breathing: a randomized controlled trial. Int Psychogeriatr. 2015 Jan; 27(1):168-70. PMID: 25101659; PMCID: PMC4501575.
      Citations:    
    37. Drye LT, Spragg D, Devanand DP, Frangakis C, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Drye LT, Spragg D, Devanand DP, Frangakis C, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, CitAD Research Group. Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial. PLoS One. 2014; 9(6):e98426. PMID: 24914549; PMCID: PMC4051660.
      Citations:    
    38. Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, CitAD Research Group. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014 Feb 19; 311(7):682-91. PMID: 24549548; PMCID: PMC4086818.
      Citations:    
    39. Krishna V, Andrews H, Varma A, Mintzer J, Kindy MS, Guest J, Krishna V, Andrews H, Varma A, Mintzer J, Kindy MS, Guest J. Spinal cord injury: how can we improve the classification and quantification of its severity and prognosis? J Neurotrauma. 2014 Feb 01; 31(3):215-27. PMID: 23895105; PMCID: PMC3904531.
      Citations:    
    40. Orr RK, Hoehn JL, Col NF, Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Zachariah S, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Segal Y, Peduzzi PN, Guarino PD. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014 Jan 01; 311(1):33-44. PMID: 24381967; PMCID: PMC4109898.
      Citations:    
    41. Flynn Longmire CV, Drye LT, Frangakis CE, Martin BK, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, Flynn Longmire CV, Drye LT, Frangakis CE, Martin BK, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, DIADS-2 Research Group. Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2. Am J Geriatr Psychiatry. 2014 Jan; 22(1):14-24. PMID: 24314887; PMCID: PMC3910508.
      Citations:    
    42. Lanctôt KL, Chau SA, Herrmann N, Drye LT, Rosenberg PB, Scherer RW, Black SE, Vaidya V, Bachman DL, Mintzer JE, Lanct?t KL, Chau SA, Herrmann N, Drye LT, Rosenberg PB, Scherer RW, Black SE, Vaidya V, Bachman DL, Mintzer JE. Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial. Int Psychogeriatr. 2014 Feb; 26(2):239-46. PMID: 24169147; PMCID: PMC3927455.
      Citations:    
    43. Rosenberg PB, Lanctôt KL, Drye LT, Herrmann N, Scherer RW, Bachman DL, Mintzer JE, Rosenberg PB, Lanct?t KL, Drye LT, Herrmann N, Scherer RW, Bachman DL, Mintzer JE. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry. 2013 Aug; 74(8):810-6. PMID: 24021498; PMCID: PMC3902018.
      Citations:    
    44. Wang H, Fernandes L, Oster S, Takeda M, Brodaty H, Mintzer JE, Wang H, Fernandes L, Oster S, Takeda M, Brodaty H, Mintzer JE. The state of psychogeriatrics in different regions of the world: challenges and opportunities. Int Psychogeriatr. 2013 Oct; 25(10):1563-9. PMID: 23845448.
      Citations:    
    45. Orr RK, Hoehn JL, Col NF, Dysken MW, Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente M, Pallaki M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Carney S, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Vatassery G. Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data. Alzheimers Dement. 2014 Jan; 10(1):36-44. PMID: 23583234; PMCID: PMC4128187.
      Citations:    
    46. Drye LT, Scherer RW, Lanctôt KL, Rosenberg PB, Herrmann N, Bachman D, Mintzer JE, Drye LT, Scherer RW, Lanct?t KL, Rosenberg PB, Herrmann N, Bachman D, Mintzer JE, ADMET Research Group. Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET). Am J Geriatr Psychiatry. 2013 Jun; 21(6):549-59. PMID: 23567407; PMCID: PMC3402588.
      Citations:    
    47. Horner MD, Mintzer JE, Turner TH, Edmiston KR, Brawman-Mintzer O, Horner MD, Mintzer JE, Turner TH, Edmiston KR, Brawman-Mintzer O. Attentional functioning in patients with posttraumatic stress disorder: a preliminary study. CNS Spectr. 2013 Apr; 18(2):90-4. PMID: 23298713.
      Citations:    
    48. Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, Depression in Alzheimer?s Disease Study?2 Research Group. Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. Am J Geriatr Psychiatry. 2012 Dec; 20(12):1036-44. PMID: 23032478; PMCID: PMC3508666.
      Citations:    
    49. Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Levin B, Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Levin B. Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med. 2012 Oct 18; 367(16):1497-507. PMID: 23075176; PMCID: PMC3490406.
      Citations:    
    50. Ruiz A, Hernández I, Ronsende-Roca M, González-Pérez A, Rodriguez-Noriega E, Ramírez-Lorca R, Mauleón A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayán J, Becker JT, Real LM, Tárraga L, Ballard C, Terrin M, Sherman S, Payami H, López OL, Mintzer JE, Boada M, Ruiz A, Hern?ndez I, Ronsende-Roca M, Gonz?lez-P?rez A, Rodriguez-Noriega E, Ram?rez-Lorca R, Maule?n A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gay?n J, Becker JT, Real LM, T?rraga L, Ballard C, Terrin M, Sherman S, Payami H, L?pez OL, Mintzer JE, Boada M. Exploratory analysis of seven Alzheimer's disease genes: disease progression. Neurobiol Aging. 2013 Apr; 34(4):1310.e1-7. PMID: 23036585; PMCID: PMC4097044.
      Citations:    
    51. Salloway S, Mintzer J, Cummings JL, Geldmacher D, Sun Y, Yardley J, Mackell J, Salloway S, Mintzer J, Cummings JL, Geldmacher D, Sun Y, Yardley J, Mackell J. Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2012 Sep; 27(6):421-32. PMID: 22930699.
      Citations:    
    52. Devanand DP, Mintzer J, Schultz S, Sultzer D, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Andrews H, Levin B, Devanand DP, Mintzer J, Schultz S, Sultzer D, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Andrews H, Levin B. The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design. Am J Geriatr Psychiatry. 2012 Apr; 20(4):362-73. PMID: 21407047; PMCID: PMC3146556.
      Citations:    
    53. Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM, Weiner M, Aisen P, Petersen R, Jack CR, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, Carmichael O, Olichney J, Kittur S, Borrie M, Lee TY, Bartha R, Johnson S, Asthana S, Carlsson CM, Potkin SG, Preda A, Nguyen D, Tariot P, Fleisher A, Reeder S, Bates V, Capote H, Rainka M, Scharre DW, Kataki M, Zimmerman EA, Celmins D, Brown AD, Pearlson GD, Blank K, Anderson K, Santulli RB, Schwartz ES, Sink KM, Williamson JD, Garg P, Watkins F, Ott BR, Querfurth H, Tremont G, Salloway S, Malloy P, Correia S, Rosen HJ, Miller BL, Mintzer J, Longmire CF, Spicer K, Finger E, Rachinsky I, Drost D, Jernigan T, McCabe C, Grant E, Ernst T, Kuperman J, Chung Y, Murray S, Bloss C, Darst B, Pritchett L, Saito A, Amaral D, DiNino M, Eyngorina B, Sowell E, Houston S, Soderberg L, Kaufmann W, van Zijl P, Rizzo-Busack H, Javid M, Mehta N, Ruberry E, Powers A, Rosen B, Gebhard N, Manigan H, Frazier J, Kennedy D, Yakutis L, Hill M, Gruen J, Bosson-Heenan J, Carlson H, Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM, Alzheimer's Disease Neuroimaging Initiative, Pediatric Imaging, Neurocognition, and Genetics Study, Weiner M, Aisen P, Petersen R, Jack CR, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, et al. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3985-90. PMID: 22343285; PMCID: PMC3309762.
      Citations:    
    54. Drye LT, Ismail Z, Porsteinsson AP, Rosenberg PB, Weintraub D, Marano C, Pelton G, Frangakis C, Rabins PV, Munro CA, Meinert CL, Devanand DP, Yesavage J, Mintzer JE, Schneider LS, Pollock BG, Lyketsos CG, Drye LT, Ismail Z, Porsteinsson AP, Rosenberg PB, Weintraub D, Marano C, Pelton G, Frangakis C, Rabins PV, Munro CA, Meinert CL, Devanand DP, Yesavage J, Mintzer JE, Schneider LS, Pollock BG, Lyketsos CG, CitAD Research Group. Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement. 2012; 8(2):121-30. PMID: 22301195; PMCID: PMC3333484.
      Citations:    
    55. Peters ME, Vaidya V, Drye LT, Rosenberg PB, Martin BK, Porsteinsson AP, Frangakis CE, Mintzer J, Weintraub D, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, Avramopoulos D, Dimitri A, Peters ME, Vaidya V, Drye LT, Rosenberg PB, Martin BK, Porsteinsson AP, Frangakis CE, Mintzer J, Weintraub D, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, Avramopoulos D, Dimitri A, DIADS-2 Research Group. Sertraline for the treatment of depression in Alzheimer disease: genetic influences. J Geriatr Psychiatry Neurol. 2011 Dec; 24(4):222-8. PMID: 22228829; PMCID: PMC3535452.
      Citations:    
    56. Mintzer J, O'Neill C, Mintzer J, O'Neill C. Depression in Alzheimer's disease: consequence or contributing factor? Expert Rev Neurother. 2011 Nov; 11(11):1501-3. PMID: 22014127.
      Citations:    
    57. Orr RK, Hoehn JL, Col NF, Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, DIADS-2 Research Group. Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ? 2 (DIADS-2)? Int J Geriatr Psychiatry. 2011 Jun; 26(6):573-83. PMID: 20672243; PMCID: PMC3414254.
      Citations:    
    58. Spampinato MV, Rumboldt Z, Hosker RJ, Mintzer JE, Spampinato MV, Rumboldt Z, Hosker RJ, Mintzer JE, Alzheimer's Disease Neuroimaging Initiative. Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. Radiology. 2011 Mar; 258(3):843-52. PMID: 21163916; PMCID: PMC6939949.
      Citations:    
    59. Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, DIADS-2 Research Group. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry. 2010 Apr; 18(4):332-40. PMID: 20220589; PMCID: PMC2849739.
      Citations:    
    60. Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, DIADS-2 Research Group. Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry. 2010 Feb; 18(2):136-45. PMID: 20087081; PMCID: PMC2842121.
      Citations:    
    61. Bachman DL, Stuckey M, Ebeling M, Wagner MT, Evans WJ, Hirth V, Walker A, Memon M, Joglekar R, Faison W, Mintzer JE, Bachman DL, Stuckey M, Ebeling M, Wagner MT, Evans WJ, Hirth V, Walker A, Memon M, Joglekar R, Faison W, Mintzer JE. Establishment of a predominantly African-American cohort for the study of Alzheimer's disease: the South Carolina Alzheimer's disease clinical core. Dement Geriatr Cogn Disord. 2009; 27(4):329-36. PMID: 19276625.
      Citations:    
    62. McNeal KM, Meyer RP, Lukacs K, Senseney A, Mintzer J, McNeal KM, Meyer RP, Lukacs K, Senseney A, Mintzer J. Using risperidone for Alzheimer's dementia-associated psychosis. Expert Opin Pharmacother. 2008 Oct; 9(14):2537-43. PMID: 18778191.
      Citations:    
    63. Laditka JN, Laditka SB, Cornman CB, Porter CN, Davis DR, Mintzer J, Laditka JN, Laditka SB, Cornman CB, Porter CN, Davis DR, Mintzer J. Notably higher rates of vascular risk factors and dementia among African Americans in South Carolina: opportunities for public health intervention. J S C Med Assoc. 2008 Oct; 104(7):219-22. PMID: 19058734.
      Citations:    
    64. Salloway S, Mintzer J, Weiner MF, Cummings JL, Salloway S, Mintzer J, Weiner MF, Cummings JL. Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement. 2008 Mar; 4(2):65-79. PMID: 18631951.
      Citations:    
    65. Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT, Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT, Memantine MEM-MD-12 Study Group. Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Curr Alzheimer Res. 2008 Feb; 5(1):83-9. PMID: 18288936.
      Citations:    
    66. Kirbach S, Simpson K, Nietert PJ, Mintzer J, Kirbach S, Simpson K, Nietert PJ, Mintzer J. A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease. Clin Drug Investig. 2008; 28(5):291-303. PMID: 18407715.
      Citations:    
    67. Mintzer JE, Tune LE, Breder CD, Swanink R, Marcus RN, McQuade RD, Forbes A, Mintzer JE, Tune LE, Breder CD, Swanink R, Marcus RN, McQuade RD, Forbes A. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. Am J Geriatr Psychiatry. 2007 Nov; 15(11):918-31. PMID: 17974864.
      Citations:    
    68. Broadway J, Mintzer J, Broadway J, Mintzer J. The many faces of psychosis in the elderly. Curr Opin Psychiatry. 2007 Nov; 20(6):551-8. PMID: 17921754.
      Citations:    
    69. Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H, Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int J Geriatr Psychiatry. 2007 May; 22(5):475-84. PMID: 17471598.
      Citations:    
    70. Faison WE, Schultz SK, Aerssens J, Alvidrez J, Anand R, Farrer LA, Jarvik L, Manly J, McRae T, Murphy GM, Olin JT, Regier D, Sano M, Mintzer JE, Faison WE, Schultz SK, Aerssens J, Alvidrez J, Anand R, Farrer LA, Jarvik L, Manly J, McRae T, Murphy GM, Olin JT, Regier D, Sano M, Mintzer JE. Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future. Int Psychogeriatr. 2007 Jun; 19(3):539-58. PMID: 17451614.
      Citations:    
    71. Wagner MT, Wymer JH, Carlozzi NE, Bachman D, Walker A, Mintzer J, Wagner MT, Wymer JH, Carlozzi NE, Bachman D, Walker A, Mintzer J, Alzheimer Study Group. Preliminary examination of progression of Alzheimer's disease in a rural Southern African American cohort. Arch Clin Neuropsychol. 2007 Mar; 22(3):405-14. PMID: 17296283.
      Citations:    
    72. Zhong KX, Tariot PN, Mintzer J, Minkwitz MC, Devine NA, Zhong KX, Tariot PN, Mintzer J, Minkwitz MC, Devine NA. Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study. Curr Alzheimer Res. 2007 Feb; 4(1):81-93. PMID: 17316169.
      Citations:    
    73. Martin BK, Frangakis CE, Rosenberg PB, Mintzer JE, Katz IR, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Niederehe G, Lyketsos CG, Martin BK, Frangakis CE, Rosenberg PB, Mintzer JE, Katz IR, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Niederehe G, Lyketsos CG. Design of Depression in Alzheimer's Disease Study-2. Am J Geriatr Psychiatry. 2006 Nov; 14(11):920-30. PMID: 17068314.
      Citations:    
    74. Tariot PN, Schneider L, Katz IR, Mintzer JE, Street J, Copenhaver M, Williams-Hughes C, Tariot PN, Schneider L, Katz IR, Mintzer JE, Street J, Copenhaver M, Williams-Hughes C. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial. Am J Geriatr Psychiatry. 2006 Sep; 14(9):767-76. PMID: 16905684.
      Citations:    
    75. Mintzer J, Greenspan A, Caers I, Van Hove I, Kushner S, Weiner M, Gharabawi G, Schneider LS, Mintzer J, Greenspan A, Caers I, Van Hove I, Kushner S, Weiner M, Gharabawi G, Schneider LS. Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial. Am J Geriatr Psychiatry. 2006 Mar; 14(3):280-91. PMID: 16505133.
      Citations:    
    76. Mintzer JE, Mintzer JE. Introduction: the clinical impact of agitation in various psychiatric disorders: management consensus and controversies. J Clin Psychiatry. 2006; 67 Suppl 10:3-5. PMID: 16965189.
      Citations:    
    77. Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L, Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L, Alzheimer's Disease Cooperative Study, Valproate Nursing Home Study Group. Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatry. 2005 Nov; 13(11):942-9. PMID: 16286437.
      Citations:    
    78. Granholm AC, Bachman D, Mintzer J, Sambamurti K, Granholm AC, Bachman D, Mintzer J, Sambamurti K. Commentary: "Ceramide and cholesterol: possible connections between normal aging of the brain and Alzheimer's disease. Just hypotheses or molecular pathways to be identified?" by Claudio Costantini, Rekha M.K. Kolasani, Luigi Puglielli. Alzheimers Dement. 2005 Jul; 1(1):53-4. PMID: 19595818.
      Citations:    
    79. Faison WE, Mintzer JE, Faison WE, Mintzer JE. The growing, ethnically diverse aging population: is our field advancing with it? Am J Geriatr Psychiatry. 2005 Jul; 13(7):541-4. PMID: 16009729.
      Citations:    
    80. Rosenberg PB, Onyike CU, Katz IR, Porsteinsson AP, Mintzer JE, Schneider LS, Rabins PV, Meinert CL, Martin BK, Lyketsos CG, Rosenberg PB, Onyike CU, Katz IR, Porsteinsson AP, Mintzer JE, Schneider LS, Rabins PV, Meinert CL, Martin BK, Lyketsos CG, Depression of Alzheimer's Disease Study. Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'. Int J Geriatr Psychiatry. 2005 Feb; 20(2):119-27. PMID: 15660424.
      Citations:    
    81. Cohen-Mansfield J, Mintzer JE, Cohen-Mansfield J, Mintzer JE. Time for change: the role of nonpharmacological interventions in treating behavior problems in nursing home residents with dementia. Alzheimer Dis Assoc Disord. 2005 Jan-Mar; 19(1):37-40. PMID: 15764870.
      Citations:    
    82. Mintzer JE, Mullen JA, Sweitzer DE, Mintzer JE, Mullen JA, Sweitzer DE. A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone. Curr Med Res Opin. 2004 Sep; 20(9):1483-91. PMID: 15383198.
      Citations:    
    83. Sambamurti K, Granholm AC, Kindy MS, Bhat NR, Greig NH, Lahiri DK, Mintzer JE, Sambamurti K, Granholm AC, Kindy MS, Bhat NR, Greig NH, Lahiri DK, Mintzer JE. Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors. Curr Drug Targets. 2004 Aug; 5(6):517-28. PMID: 15270198.
      Citations:    
    84. Mintzer JE, Mintzer JE. What are the challenges faced by psychiatrists in the management of Alzheimer's disease? CNS Spectr. 2004 Jul; 9(7 Suppl 5):13-5. PMID: 15241295.
      Citations:    
    85. Mintzer JE, Mintzer JE. Assessing current practice in Alzheimer's disease. CNS Spectr. 2004 Jul; 9(7 Suppl 5):5. PMID: 15241293.
      Citations:    
    86. Nahas Z, Li X, Kozel FA, Mirzki D, Memon M, Miller K, Yamanaka K, Anderson B, Chae JH, Bohning DE, Mintzer J, George MS, Nahas Z, Li X, Kozel FA, Mirzki D, Memon M, Miller K, Yamanaka K, Anderson B, Chae JH, Bohning DE, Mintzer J, George MS. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress Anxiety. 2004; 19(4):249-56. PMID: 15274174.
      Citations:    
    87. Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T, Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry. 2004 Jan; 19(1):9-18. PMID: 14716694.
      Citations: 44     Fields:    Translation:HumansCTClinical Trials
    88. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O'Brien J, Playfer J, Reid W, McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O'Brien J, Playfer J, Reid W, International Psychogeriatric Association Expert Meeting on DLB. Dementia with Lewy bodies. Lancet Neurol. 2004 Jan; 3(1):19-28. PMID: 14693108.
      Citations: 191     Fields:    Translation:Humans
    89. Carter RE, Rose DA, Palesch YY, Mintzer JE, Carter RE, Rose DA, Palesch YY, Mintzer JE. Alzheimer's Disease in the Family Practice Setting: Assessment of a Screening Tool. Prim Care Companion J Clin Psychiatry. 2004; 6(6):234-238. PMID: 15614310; PMCID: PMC535649.
      Citations:    
    90. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ, Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ, Alzheimer's Disease Cooperative Study. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66. PMID: 14732621.
      Citations: 301     Fields:    Translation:HumansCTClinical Trials
    91. Frueh BC, Elhai JD, Hamner MB, Magruder KM, Sauvageot JA, Mintzer J, Frueh BC, Elhai JD, Hamner MB, Magruder KM, Sauvageot JA, Mintzer J. Elderly veterans with combat-related posttraumatic stress disorder in specialty care. J Nerv Ment Dis. 2004 Jan; 192(1):75-9. PMID: 14718781.
      Citations: 2     Fields:    Translation:Humans
    92. Mintzer J, Targum SD, Mintzer J, Targum SD. Psychosis in elderly patients: classification and pharmacotherapy. J Geriatr Psychiatry Neurol. 2003 Dec; 16(4):199-206. PMID: 14653427.
      Citations: 1     Fields:    Translation:Humans
    93. Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, Perdomo C, Ieni JR, Rogers S, Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, Perdomo C, Ieni JR, Rogers S. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry. 2003 Nov; 160(11):2003-11. PMID: 14594748.
      Citations: 81     Fields:    Translation:HumansCellsCTClinical Trials
    94. Mintzer J, Armstrong D, Faison WE, Mintzer J, Armstrong D, Faison WE. Combination pharmacotherapy in Alzheimer's disease. Dialogues Clin Neurosci. 2003 Sep; 5(3):299-305. PMID: 22033825; PMCID: PMC3181636.
      Citations:    
    95. Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD, Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD, Donepezil 308 Study Group. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003 Aug 26; 61(4):479-86. PMID: 12939421.
      Citations: 77     Fields:    Translation:HumansCTClinical Trials
    96. Mintzer JE, Kershaw P, Mintzer JE, Kershaw P. The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure. Int J Geriatr Psychiatry. 2003 Apr; 18(4):292-7. PMID: 12673604.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    97. Mintzer JE, Mintzer JE. The search for better noncholinergic treatment options for Alzheimer's disease. J Clin Psychiatry. 2003; 64 Suppl 9:18-22. PMID: 12934970.
      Citations: 2     Fields:    Translation:Humans
    98. DeVane CL, Mintzer J, DeVane CL, Mintzer J. Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update. Psychopharmacol Bull. 2003; 37(4):116-32. PMID: 15131522.
      Citations:    
    99. Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM, Feldman PD, Mintzer JE, Beckett LM, Breier A, Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM, Feldman PD, Mintzer JE, Beckett LM, Breier A. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology. 2002 Apr; 26(4):494-504. PMID: 11927174.
      Citations: 35     Fields:    Translation:HumansCTClinical Trials
    100. Mintzer J, Faison W, Street JS, Sutton VK, Breier A, Mintzer J, Faison W, Street JS, Sutton VK, Breier A. Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis. Int J Geriatr Psychiatry. 2001 Dec; 16 Suppl 1:S71-7. PMID: 11748790.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    101. Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D, Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D. Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial. J Neurol Neurosurg Psychiatry. 2001 Nov; 71(5):589-95. PMID: 11606667; PMCID: PMC1737604.
      Citations: 57     Fields:    Translation:HumansCellsCTClinical Trials
    102. Risch SC, McGurk S, Horner MD, Nahas Z, Owens SD, Molloy M, Gilliard C, Christie S, Markowitz JS, DeVane CL, Mintzer J, George MS, Risch SC, McGurk S, Horner MD, Nahas Z, Owens SD, Molloy M, Gilliard C, Christie S, Markowitz JS, DeVane CL, Mintzer J, George MS. A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates. Neurocase. 2001; 7(2):105-10. PMID: 11320158.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    103. Orr RK, Hoehn JL, Col NF, Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000 Sep; 93(9):457-62. PMID: 11089480; PMCID: PMC1298101.
      Citations: 89     Fields:    Translation:Humans
    104. Thal LJ, Ferguson JM, Mintzer J, Raskin A, Targum SD, Thal LJ, Ferguson JM, Mintzer J, Raskin A, Targum SD. A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease. Neurology. 1999 Apr 12; 52(6):1146-52. PMID: 10214735.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    105. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M, Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry. 1999 Feb; 60(2):107-15. PMID: 10084637.
      Citations: 121     Fields:    Translation:HumansCTClinical Trials
    106. Mintzer J, Brawman-Mintzer O, Mirski DF, Unger R, Nietert P, Meeks A, Sampson R, Mintzer J, Brawman-Mintzer O, Mirski DF, Unger R, Nietert P, Meeks A, Sampson R. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Biol Psychiatry. 1998 Nov 01; 44(9):918-21. PMID: 9807649.
      Citations: 6     Fields:    Translation:Humans
    107. Mintzer JE, Hoernig KS, Mirski DF, Mintzer JE, Hoernig KS, Mirski DF. Treatment of agitation in patients with dementia. Clin Geriatr Med. 1998 Feb; 14(1):147-75. PMID: 9456340.
      Citations: 3     Fields:    Translation:HumansAnimals
    108. Mintzer J, Nietert P, Costa K, Rust P, Hoernig K, Mintzer J, Nietert P, Costa K, Rust P, Hoernig K. Identifying persons with dementia by use of a caregiver telephone interview. Am J Geriatr Psychiatry. 1998; 6(2):176-9. PMID: 9581213.
      Citations: 2     Fields:    Translation:Humans
    109. Mintzer JE, Colenda C, Waid LR, Lewis L, Meeks A, Stuckey M, Bachman DL, Saladin M, Sampson RR, Mintzer JE, Colenda C, Waid LR, Lewis L, Meeks A, Stuckey M, Bachman DL, Saladin M, Sampson RR. Effectiveness of a continuum of care using brief and partial hospitalization for agitated dementia patients. Psychiatr Serv. 1997 Nov; 48(11):1435-9. PMID: 9355171.
      Citations: 1     Fields:    Translation:Humans
    110. Markowitz JS, Gill HS, Devane CL, Mintzer JE, Markowitz JS, Gill HS, Devane CL, Mintzer JE. Fluoroquinolone inhibition of clozapine metabolism. Am J Psychiatry. 1997 Jun; 154(6):881. PMID: 9167522.
      Citations: 7     Fields:    Translation:Humans
    111. Jackson CW, Pitner JK, Mintzer JE, Jackson CW, Pitner JK, Mintzer JE. Zolpidem for the treatment of agitation in elderly demented patients. J Clin Psychiatry. 1996 Aug; 57(8):372-3. PMID: 8752023.
      Citations: 1     Fields:    Translation:Humans
    112. Mintzer JE, Brown SA, Hoernig KS, Mintzer JE, Brown SA, Hoernig KS. Alzheimer's disease and managed care: challenges and strategies. J S C Med Assoc. 1996 Jun; 92(6):255-60. PMID: 8691821.
      Citations:    Fields:    Translation:Humans
    113. Mintzer JE, Brawman-Mintzer O, Mintzer JE, Brawman-Mintzer O. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J Clin Psychiatry. 1996; 57 Suppl 7:55-63; discussion 73-5. PMID: 8690698.
      Citations: 9     Fields:    Translation:Humans
    114. Mintzer JE, Nietert P, Costa K, Waid LR, Mintzer JE, Nietert P, Costa K, Waid LR. Cross-cultural perspectives: agitation in demented patients in the United States. Int Psychogeriatr. 1996; 8 Suppl 3:487-90; discussion 491-2. PMID: 9154613.
      Citations: 1     Fields:    Translation:Humans
    115. Pitner JK, Mintzer JE, Pennypacker LC, Jackson CW, Pitner JK, Mintzer JE, Pennypacker LC, Jackson CW. Efficacy and adverse effects of clozapine in four elderly psychotic patients. J Clin Psychiatry. 1995 May; 56(5):180-5. PMID: 7737956.
      Citations: 7     Fields:    Translation:Humans
    116. Jackson C, Carson W, Markowitz J, Mintzer J, Jackson C, Carson W, Markowitz J, Mintzer J. SIADH associated with fluoxetine and sertraline therapy. Am J Psychiatry. 1995 May; 152(5):809-10. PMID: 7726326.
      Citations: 5     Fields:    Translation:Humans
    117. Mintzer JE, Bachman D, Mintzer JE, Bachman D. New approaches in the treatment of Alzheimer's disease. J S C Med Assoc. 1994 Nov; 90(11):553-9. PMID: 7853859.
      Citations:    Fields:    Translation:Humans
    118. Mintzer JE, Lewis L, Pennypacker L, Pitner J, Simpson W, Bachman D, Wohlreich GM, Meeks A, Hunt S, Herman K, Mintzer JE, Lewis L, Pennypacker L, Pitner J, Simpson W, Bachman D, Wohlreich GM, Meeks A, Hunt S, Herman K, et al. A new approach for the management of acute psychiatric disorders in elderly demented patients. J S C Med Assoc. 1994 Aug; 90(8):373-6. PMID: 7934004.
      Citations: 1     Fields:    Translation:Humans
    119. Mintzer JE, Rubert MP, Herman KC, Mintzer JE, Rubert MP, Herman KC. Caregiving for Hispanic Alzheimer's disease patients: understanding the problem. Am J Geriatr Psychiatry. 1994; 2(1):32-8. PMID: 21629005.
      Citations:    
    120. Mintzer JE, Lewis L, Pennypaker L, Simpson W, Bachman D, Wohlreich G, Meeks A, Hunt S, Sampson R, Mintzer JE, Lewis L, Pennypaker L, Simpson W, Bachman D, Wohlreich G, Meeks A, Hunt S, Sampson R. Behavioral Intensive Care Unit (BICU): a new concept in the management of acute agitated behavior in elderly demented patients. Gerontologist. 1993 Dec; 33(6):801-6. PMID: 8314107.
      Citations: 2     Fields:    Translation:Humans
    121. Loewenstein DA, Ardila A, Rosselli M, Hayden S, Duara R, Berkowitz N, Linn-Fuentes P, Mintzer J, Norville M, Eisdorfer C, Loewenstein DA, Ardila A, Rosselli M, Hayden S, Duara R, Berkowitz N, Linn-Fuentes P, Mintzer J, Norville M, Eisdorfer C. A comparative analysis of functional status among Spanish- and English-speaking patients with dementia. J Gerontol. 1992 Nov; 47(6):P389-94. PMID: 1430861.
      Citations: 14     Fields:    Translation:Humans
    122. Mintzer JE, Rubert MP, Loewenstein D, Gamez E, Millor A, Quinteros R, Flores L, Miller M, Rainerman A, Eisdorfer C, Mintzer JE, Rubert MP, Loewenstein D, Gamez E, Millor A, Quinteros R, Flores L, Miller M, Rainerman A, Eisdorfer C. Daughters caregiving for Hispanic and non-Hispanic Alzheimer patients: does ethnicity make a difference? Community Ment Health J. 1992 Aug; 28(4):293-303. PMID: 1643838.
      Citations: 6     Fields:    Translation:Humans
    123. Mintzer JE, Macera CA, Mintzer JE, Macera CA. Prevalence of depressive symptoms among white and African-American caregivers of demented patients. Am J Psychiatry. 1992 Apr; 149(4):575-6. PMID: 1554055.
      Citations: 1     Fields:    Translation:Humans
    124. Loewenstein DA, D'Elia L, Guterman A, Eisdorfer C, Wilkie F, LaRue A, Mintzer J, Duara R, Loewenstein DA, D'Elia L, Guterman A, Eisdorfer C, Wilkie F, LaRue A, Mintzer J, Duara R. The occurrence of different intrusive errors in patients with Alzheimer's disease, multiple cerebral infarctions, and major depression. Brain Cogn. 1991 May; 16(1):104-17. PMID: 1854466.
      Citations: 10     Fields:    Translation:Humans
    125. Oppenheim G, Mintzer J, Halperin Y, Eliakim R, Stessman J, Ebstein RP, Oppenheim G, Mintzer J, Halperin Y, Eliakim R, Stessman J, Ebstein RP. Acute desensitization of lymphocyte beta-adrenergic-stimulated adenylate cyclase in old age and Alzheimer's disease. Life Sci. 1984 Oct 22; 35(17):1795-802. PMID: 6090850.
      Citations: 3     Fields:    Translation:HumansCells
    Mintzer's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (379)
    Explore
    _
    Co-Authors (34)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _